review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1177/107327480901604S03 |
P698 | PubMed publication ID | 20010512 |
P50 | author | Evelyn R Hermes-DeSantis | Q41205981 |
P2093 | author name string | Steven D Gore | |
P304 | page(s) | 2-10 | |
P577 | publication date | 2009-10-01 | |
P1433 | published in | Cancer Control | Q15724614 |
P1476 | title | Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes | |
P478 | volume | 16 Suppl |
Q41471081 | A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial |
Q38737783 | Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line |
Q33706374 | BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins |
Q34764504 | Biology, risk stratification, and therapy of pediatric acute leukemias: an update |
Q26865904 | Emerging therapeutic biomarkers in endometrial cancer |
Q33972354 | Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics |
Q26801573 | Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise? |
Q38248180 | Stopping higher-risk myelodysplastic syndrome in its tracks |
Search more.